Ascendis Pharma A/S at Citi BioPharma Conference Transcript
Hello again, and welcome to the Citi 18th Annual BioPharma Conference. We are coming up on the end here, but now before that, we have with us on stage Ascendis. They've certainly had some news -- a bundle of news yesterday so they will be able to talk about more specifically and others, which we'll be teased with but will not probably get too much information on. But beforehand, you can -- your requisite disclosures.
Thank you, David. We may make forward-looking comments during this presentation. Actual results may differ materially from those expressed or implied and you should not place undue reliance on these statements. For information concerning the factors that could cause actual results to differ materially, please see the Risk Factors section of our most recent annual report on Form 20-F. Before I turn this back over to David, I want to make a comment regarding our PTH regulatory status of -- our U.S. regulatory status of TransCon PTH. Jan provided a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
